Status:
COMPLETED
Swaziland HIV Incidence Measurement Survey 2
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Centers for Disease Control and Prevention
Ministry of Health, Swaziland
Conditions:
HIV/AIDS
Eligibility:
All Genders
Brief Summary
The second Swaziland HIV Incidence Measurement Survey (SHIMS 2, 2016), is a population based HIV Impact Assessment (PHIA) that will assess the prevalence of key human immunodeficiency virus (HIV)-rela...
Detailed Description
After nearly three decades of Swaziland's national HIV response, a rigorous, population-based measure of the above biological endpoints will provide a valuable follow-up assessment of the impact of th...
Eligibility Criteria
Inclusion
- Participants 18 Years and Older:
- Resides in selected household or spent the night before the survey there, per above definitions, and
- Self-reported age 18 years and above, and
- Ability and willingness to provide written informed consent in English or siSwati
- Participants 10-17 Years:
- Resides in selected household or spent the night before the survey there, per above definitions, and
- Self-reported age 10-17 years, and
- Ability and willingness to provide written assent and parent/guardian able and willing to provide written informed consent/permission in English or siSwati, or
- For children with special circumstances 12-17 years old, ability and willingness to provide written informed consent in English or siSwati
- Participants 0-9 Years:
- Resides in selected household or spent the night before the survey there, per above definitions, and
- Parent/guardian or child with special circumstances who reports subject's age as 0-9 years, and
- Parent/guardian/child with special circumstances is able and willing to provide written, informed consent/permission in English or siSwati
Exclusion
- Persons who are unable to give consent due to cognitive impairment or intellectual disability will not be eligible to participate. (Individuals with other disabilities who are otherwise able to give written informed consent, mark, or thumb print will be offered survey participation.)
Key Trial Info
Start Date :
August 30 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
15429 Patients enrolled
Trial Details
Trial ID
NCT04117984
Start Date
August 30 2016
End Date
December 31 2019
Last Update
February 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ICAP at Columbia University
Mbabane, Eswatini